Atlas Trials

A Study to Evaluate the Safety and Tolerability of RAG-18 in Pediatric Patients With Duchenne Muscular Dystrophy

Clinical trial NCT07282652 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT07282652
Sponsor
Peking Union Medical College Hospital
Status
ACTIVE_NOT_RECRUITING
Phase
Early Phase 1
Study type
INTERVENTIONAL
Duchenne Muscular Dystrophy (DMD)
Start date
2025-12-12
Primary completion
2026-11-01
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.